ALSO NOTED: FDA accepts Centocor marketing app; AEterna files INDA; and much more...

> The FDA has accepted Centocor's marketing application for Remicade as a treatment for psoriatic arthritis. Report [1]

> AEterna Zentaris says it plans to file an INDA with the FDA to launch a Phase III trial of cetrorelix as a therapy for benign prostatic hyperplasia. Report [2]

> Schering-Plough is shaking up its marketing efforts in Brazil. Report [3]

> New River Pharmaceuticals has provided details on its A02 clinical abuse liability study of NRP104 at the annual meeting of the College on Problems of Drug Dependence. Report [4]

And Finally... Researchers have used stem cell technology to enable paralyzed rats to walk again. Article [5]